COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated.

Lazarinis, Nikolaos; Bossios, Apostolos; Gülen, Theo

Lazarinis, Nikolaos; Bossios, Apostolos; Gülen, Theo.

Lazarinis N; Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Bossios A; Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Gülen T; Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Clinical Immunology and Allergy Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Mastocytosis Center Karolinska, Karolinska Institutet and Karolinska University, Hospital Huddinge, Stockholm, Sweden. Electronic address: theo.gulen@regionstockholm.se.

J Allergy Clin Immunol Pract ; 10(5): 1377-1379, 2022 05.

Article in English | MEDLINE | ID: covidwho-1704497

Subject(s)

COVID-19; Mastocytosis; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Vaccination/adverse effects; Vaccines, Synthetic; mRNA Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mastocytosis / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2022 Document Type: Article Affiliation country: J.jaip.2022.01.037

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google